Business Combination, Consideration Transferred, Liabilities Incurred, Contingent Consideration

No definition available.

Name:	pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredContingentConsideration
Namespace Prefix:	pcrx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Business Combination, Consideration Transferred, Liabilities Incurred, Debt

+ References

No definition available.

+ Details

Name:	pcrx_BusinessCombinationConsiderationTransferredLiabilitiesIncurredDebt
Namespace Prefix:	pcrx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Class Of Warrant Or Right, Exercise Price, Annual Product Sales Threshold

+ References

No definition available.

+ Details

Name:	pcrx_ClassOfWarrantOrRightExercisePriceAnnualProductSalesThreshold
Namespace Prefix:	pcrx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Finite-Lived Intangible Assets, Measurement Input

+ References

No definition available.

+ Details

Name:	pcrx_FiniteLivedIntangibleAssetsMeasurementInput
Namespace Prefix:	pcrx_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Discount rate which is used to value residual cash flows generated by financial assets of the securitization, asset-backed financing arrangement, or similar transfer for initial fair value measurement.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 860
-SubTopic 20
-Section 50
-Paragraph 3
-Subparagraph (c)(1)
-URI https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719

+ Details

Name:	us-gaap_AssumptionForFairValueOnSecuritizationDateOfInterestsContinuedToBeHeldByTransferorServicingAssetsOrLiabilitiesDiscountRate
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_BusinessAcquisitionLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 30
-Paragraph 8
-URI https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 30
-Paragraph 7
-URI https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477

+ Details

Name:	us-gaap_BusinessCombinationConsiderationTransferred1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (c)(3)
-URI https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479

+ Details

Name:	us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Exercise price per share or per unit of warrants or rights outstanding.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644

+ Details

Name:	us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

No definition available.

+ Details

Name:	us-gaap_FiniteLivedIntangibleAssetUsefulLife
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (a)(1)
-URI https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275

+ Details

Name:	us-gaap_FinitelivedIntangibleAssetsAcquired1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)(1)
-URI https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585

+ Details

Name:	us-gaap_PaymentsToAcquireBusinessesGross
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	us-gaap_BusinessAcquisitionAxis=pcrx_FlexionTherapeuticsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ValuationTechniqueAxis=us-gaap_IncomeApproachValuationTechniqueMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementClassOfStockAxis=pcrx_RestrictedStockUnitsMoneyStockOptionsAndCommonStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	pcrx_AchievementOfMilestoneAxis=pcrx_AchievementOfZILRETTASalesOf250MillionMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_StatementScenarioAxis=srt_ScenarioForecastMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	pcrx_AchievementOfMilestoneAxis=pcrx_AchievementOfZILRETTASalesOf375MillionMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	pcrx_AchievementOfMilestoneAxis=pcrx_AchievementOfZILRETTASalesOf500MillionMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	pcrx_AchievementOfMilestoneAxis=pcrx_AchievementOfFDAApprovalOfFX201Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	pcrx_AchievementOfMilestoneAxis=pcrx_AchievementOfFDAApprovalOfFX301Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

FLEXION ACQUISITION - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands		13 Months Ended	109 Months Ended
	Nov. 19, 2021	Dec. 31, 2022	Dec. 31, 2030
Flexion
Business Acquisition [Line Items]
Consideration transferred	$ 578,845
Cash paid to acquire business	533,604
Retirement of term loan	85,100
Contingent value right	45,241
Additional amount payable to holders of the CVRs	380,200
Flexion \| Developed technologies
Business Acquisition [Line Items]
Finite-lived intangible assets acquired	$ 480,000
Useful life	9 years 8 months 12 days
Flexion \| Developed technologies \| Measurement Input, Discount Rate \| Valuation, Income Approach
Business Acquisition [Line Items]
Discount rate, measurement input	17.50%
Flexion \| Acquired IPR&D
Business Acquisition [Line Items]
Finite-lived intangible assets acquired	$ 60,000
Flexion \| Acquired IPR&D \| Measurement Input, Discount Rate \| Valuation Technique, Discounted Cash Flow
Business Acquisition [Line Items]
Projected future cash flows discounted, rate	18.00%
Flexion \| RSUs, In-The-Money Stock Options, and Common Stock
Business Acquisition [Line Items]
Cash paid to acquire business		$ 448,500
Achievement of ZILRETTA Sales of $250 Million
Business Acquisition [Line Items]
Contingent value right (in dollars per share)	$ 1.00
Achievement of ZILRETTA Sales of $250 Million \| Forecast
Business Acquisition [Line Items]
Annual product sales threshold			$ 250,000
Achievement of ZILRETTA Sales of $375 Million
Business Acquisition [Line Items]
Contingent value right (in dollars per share)	2.00
Achievement of ZILRETTA Sales of $375 Million \| Forecast
Business Acquisition [Line Items]
Annual product sales threshold			375,000
Achievement of ZILRETTA Sales of $500 Million
Business Acquisition [Line Items]
Contingent value right (in dollars per share)	3.00
Achievement of ZILRETTA Sales of $500 Million \| Forecast
Business Acquisition [Line Items]
Annual product sales threshold			$ 500,000
Achievement of FDA Approval of FX-201
Business Acquisition [Line Items]
Contingent value right (in dollars per share)	1.00
Achievement of FDA Approval of FX-301
Business Acquisition [Line Items]
Contingent value right (in dollars per share)	$ 1.00